Drugs like Ozempic and Wegovy — known as glucagon-like peptide-1 receptor agonists, or GLP-1s — have made headlines and surged in popularity for their unique ability to help patients lose weight by ...

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

Discover how obesity drugs may reduce alcohol consumption alongside weight loss. Learn about this promising new research.

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Ozempic and other semaglutide drugs help people reduce their drinking, a new study has found. The drugs, best known for their ...

In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.

Semaglutide (Wegovy) may help heavy drinkers cut down on their alcohol intake in addition to losing weight, a trial has found ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...